Cardiopexy at the Time of Sleeve Gastrectomy as a Preventive Measure for Reflux.

Surg Laparosc Endosc Percutan Tech

Department of Bariatric Surgery, Orlando Regional Medical Center, Orlando Health, Orlando, FL.

Published: October 2020

Background: One of the most significant concerns after laparoscopic sleeve gastrectomy (LSG) is the new-onset or worsening of gastroesophageal reflux disease (GERD). Some patients with LSG undergo a conversion to Roux-en-Y gastric bypass (RYGB) because of severe GERD. Cardiopexy at the time of LSG may help prevent GERD. This study aims to examine the safety and effectiveness of cardiopexy at the time of LSG.

Methods: A retrospective chart review was performed on 161 consecutive patients who underwent LSG between May 1, 2017 and April 30, 2018. Of these, 79 underwent cardiopexy at the time of LSG. Weight, comorbidities, and complications were recorded at 6 months after LSG.

Results: Baseline characteristics were similar between the cardiopexy and noncardiopexy groups of patients. In the cardiopexy group, 8 (10.1%) patients reported having GERD at the time of LSG, whereas 12 (14.6%) patients did in the noncardiopexy group. At 6 months after the procedure, 5 (8.9%) patients in the cardiopexy group reported symptoms of GERD, whereas 14 (17.7%) patients did in the noncardiopexy group (P=0.15). One (1.3%) patient in the cardiopexy group and 2 (2.4%) patients in the noncardiopexy group were converted to an RYGB because of severe reflux (P=0.58). The percentage of excess body mass index loss and the percentage of total weight loss were similar between the 2 groups.

Conclusion: Cardiopexy was not associated with a reduced rate of symptomatic GERD and conversion to RYGB after 6 months.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLE.0000000000000816DOI Listing

Publication Analysis

Top Keywords

cardiopexy time
16
time lsg
12
cardiopexy group
12
patients noncardiopexy
12
noncardiopexy group
12
cardiopexy
9
sleeve gastrectomy
8
patients
8
rygb severe
8
patients cardiopexy
8

Similar Publications

Background: Surgical fundoplication remains integral in managing gastroesophageal reflux disease (GERD) by addressing gastroesophageal valve incompetence. This study introduces a novel hybrid approach, the Eversion Cruroplasty and Collar Overwrap (ECCO) procedure, aiming to combine benefits of conventional partial wrapping and posteromedial cardiopexy, considering gastric fundus anatomical peculiarities as an anti-reflux barrier.

Methods: A retrospective analysis of pediatric patients presenting with refractory GERD from 2021 to 2023 was conducted.

View Article and Find Full Text PDF

Background: Obesity is a well-known risk factor for gastroesophageal reflux disease (GERD). Even though symptoms may be mitigated or resolved with the weight loss caused by sleeve gastrectomy (SG), it may be associated with higher incidences of postoperative GERD. Ligamentum teres cardiopexy (LTC) is an alternative to Roux-en-Y gastric bypass, the gold standard treatment for GERD.

View Article and Find Full Text PDF

Trends in outcomes of 862 giant hiatus hernia repairs over 30 years.

Hernia

December 2023

Department of Upper Gastrointestinal Surgery, Concord Repatriation General Hospital, Concord, NSW, 2139, Australia.

Purpose: Laparoscopic giant hiatus hernia repair is technically difficult with ongoing debate regarding the most effective surgical technique. Repair of small hernia has been well described but data for giant hernia is variable. This study evaluated trends in outcomes of laparoscopic non-mesh repair of giant paraesophageal hernia (PEH) over 30 years.

View Article and Find Full Text PDF

Background: Severe reflux after sleeve-gastrectomy (SG) often requires conversion to Roux-en-Y-Gastric Bypass (RYGB). We performed laparoscopic Ligamentum Teres Cardiopexy (LLTC) as an alternative operation.

Materials & Methods: Ten patients had LLTC between June 2019-June 2020.

View Article and Find Full Text PDF

Cardiopexy at the Time of Sleeve Gastrectomy as a Preventive Measure for Reflux.

Surg Laparosc Endosc Percutan Tech

October 2020

Department of Bariatric Surgery, Orlando Regional Medical Center, Orlando Health, Orlando, FL.

Background: One of the most significant concerns after laparoscopic sleeve gastrectomy (LSG) is the new-onset or worsening of gastroesophageal reflux disease (GERD). Some patients with LSG undergo a conversion to Roux-en-Y gastric bypass (RYGB) because of severe GERD. Cardiopexy at the time of LSG may help prevent GERD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!